Bioasis Technologies Inc.
BIOAF · OTC
11/30/2022 | 8/31/2022 | 5/31/2022 | 2/28/2022 | |
|---|---|---|---|---|
| Market Cap | $13,060 | $12,833 | $16,147 | $19,300 |
| - Cash | $157 | $568 | $765 | $1,731 |
| + Debt | $2,214 | $2,004 | $1,773 | $1,902 |
| Enterprise Value | $15,117 | $14,268 | $17,155 | $19,471 |
| Revenue | $149 | $120 | $0 | $0 |
| % Growth | 23.7% | – | – | – |
| Gross Profit | -$72 | $89 | -$14 | -$14 |
| % Margin | -48.3% | 74% | – | – |
| EBITDA | -$664 | -$829 | $27 | -$1,588 |
| % Margin | -445.8% | -688% | – | – |
| Net Income | -$986 | -$1,090 | -$233 | -$567 |
| % Margin | -661.8% | -905.2% | – | – |
| EPS Diluted | -0.013 | -0.014 | -0.003 | -0.008 |
| % Growth | 9.4% | -334.4% | 59% | – |
| Operating Cash Flow | -$443 | -$224 | -$589 | -$681 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$443 | -$224 | -$589 | -$681 |